Role of Reactive Oxygen Species in Endothelin-Induced Hypertension

ABSTRACT—Recent reports have indicated that endothelin-induced vasoconstriction in isolated aortic vascular rings may be mediated by the production of superoxide anion. The purpose of this study was to determine the role of superoxide anion in mediating the chronic renal and hypertensive actions of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hypertension (Dallas, Tex. 1979) Tex. 1979), 2003-10, Vol.42 (4, Part 2), p.806-810
Hauptverfasser: Sedeek, Mona H, Llinas, Maria T, Drummond, Heather, Fortepiani, Lourdes, Abram, Sean R, Alexander, Barbara T, Reckelhoff, Jane F, Granger, Joey P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 810
container_issue 4, Part 2
container_start_page 806
container_title Hypertension (Dallas, Tex. 1979)
container_volume 42
creator Sedeek, Mona H
Llinas, Maria T
Drummond, Heather
Fortepiani, Lourdes
Abram, Sean R
Alexander, Barbara T
Reckelhoff, Jane F
Granger, Joey P
description ABSTRACT—Recent reports have indicated that endothelin-induced vasoconstriction in isolated aortic vascular rings may be mediated by the production of superoxide anion. The purpose of this study was to determine the role of superoxide anion in mediating the chronic renal and hypertensive actions of endothelin. Endothelin-1 (5 pmol/kg per minute) was chronically infused into the jugular vein by use of mini-osmotic pump for 9 days in male Sprague-Dawley rats and in rats treated with the superoxide anion scavenger tempol (30 mg/kg per day). Mean arterial pressure in the endothelin-1–treated rats was 141±3 mm Hg, compared with 125±2 mm Hg in control rats. Endothelin-1 increased renal vascular resistance (15.3±2.5 versus 10±1.3 mm Hg/mL per minute) and decreased renal plasma flow (6.5±0.9 versus 8.7±0.7 mL/min) in control rats. Endothelin-1 also significantly increased TBARS in the kidney and urinary 8-isoprostaglandin F2α excretion. The increase in arterial pressure in response to endothelin-1 was completely abolished by tempol (127±4 versus 127±4 mm Hg). Tempol also markedly attenuated the renal plasma flow and renal vascular resistance response to endothelin-1. Tempol also significantly decreased the level of 8-isoprostaglandin F2α in the endothelin-1–treated rats. Tempol had no effect on arterial pressure or renal hemodynamics in control rats. These data indicate that formation of reactive oxygen species may play an important role in mediating hypertension induced by chronic elevations in endothelin.
doi_str_mv 10.1161/01.HYP.0000084372.91932.BA
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_205273906</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>420432041</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5760-945b0ffd59a09271d15f73cc312a382a7def5e02a3fb2c948768e64d050461583</originalsourceid><addsrcrecordid>eNpFkN1q20AQRpfQkLhpXqGIQC-lzOyPVts7O6R1IJCSttBcLevVqFaqSM6u1NRv301s8NwMM5yZDw5jFwgFYomXgMXy4VsBr1VJoXlh0AheLOZHbIaKy1yqUrxjM0Ajc4P465S9j_ERAKWU-oSdIq-0BFPO2OJ-6CgbmuyenB_bv5Td_dv-pj77viHfUszaPrvu62FcU9f2-U1fT57qbLndUBipj-3Qf2DHjesine_7Gfv55frH1TK_vft6czW_zb3SJeRGqhU0Ta2MA8M11qgaLbwXyJ2ouNM1NYogDc2KeyMrXVZUyhoUyBJVJc7Yxe7vJgzPE8XRPg5T6FOk5aC4FgbKBH3eQT4MMQZq7Ca0Ty5sLYJ9tWcBbbJnD_bsmz27mKfjj_uEafVE9eF0rysBn_aAi951TXC9b-OBU1gJAJ44ueNehm6kEP900wsFuybXjeu3aMnLKucAAhMPedoIEP8BcL2GLg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205273906</pqid></control><display><type>article</type><title>Role of Reactive Oxygen Species in Endothelin-Induced Hypertension</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Ovid Autoload</source><creator>Sedeek, Mona H ; Llinas, Maria T ; Drummond, Heather ; Fortepiani, Lourdes ; Abram, Sean R ; Alexander, Barbara T ; Reckelhoff, Jane F ; Granger, Joey P</creator><creatorcontrib>Sedeek, Mona H ; Llinas, Maria T ; Drummond, Heather ; Fortepiani, Lourdes ; Abram, Sean R ; Alexander, Barbara T ; Reckelhoff, Jane F ; Granger, Joey P</creatorcontrib><description>ABSTRACT—Recent reports have indicated that endothelin-induced vasoconstriction in isolated aortic vascular rings may be mediated by the production of superoxide anion. The purpose of this study was to determine the role of superoxide anion in mediating the chronic renal and hypertensive actions of endothelin. Endothelin-1 (5 pmol/kg per minute) was chronically infused into the jugular vein by use of mini-osmotic pump for 9 days in male Sprague-Dawley rats and in rats treated with the superoxide anion scavenger tempol (30 mg/kg per day). Mean arterial pressure in the endothelin-1–treated rats was 141±3 mm Hg, compared with 125±2 mm Hg in control rats. Endothelin-1 increased renal vascular resistance (15.3±2.5 versus 10±1.3 mm Hg/mL per minute) and decreased renal plasma flow (6.5±0.9 versus 8.7±0.7 mL/min) in control rats. Endothelin-1 also significantly increased TBARS in the kidney and urinary 8-isoprostaglandin F2α excretion. The increase in arterial pressure in response to endothelin-1 was completely abolished by tempol (127±4 versus 127±4 mm Hg). Tempol also markedly attenuated the renal plasma flow and renal vascular resistance response to endothelin-1. Tempol also significantly decreased the level of 8-isoprostaglandin F2α in the endothelin-1–treated rats. Tempol had no effect on arterial pressure or renal hemodynamics in control rats. These data indicate that formation of reactive oxygen species may play an important role in mediating hypertension induced by chronic elevations in endothelin.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/01.HYP.0000084372.91932.BA</identifier><identifier>PMID: 12874096</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Animals ; Arterial hypertension. Arterial hypotension ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cells, Cultured ; Chronic Disease ; Cyclic N-Oxides - pharmacology ; Dinoprost - analogs &amp; derivatives ; Endothelin-1 - pharmacology ; Endothelin-1 - toxicity ; Experimental diseases ; F2-Isoprostanes - urine ; Free Radical Scavengers - pharmacology ; Hemodynamics - drug effects ; Hypertension - chemically induced ; Hypertension - metabolism ; Hypertension - physiopathology ; Kidney - metabolism ; Kidney - physiopathology ; Male ; Medical sciences ; Muscle, Smooth, Vascular - metabolism ; Rats ; Rats, Sprague-Dawley ; Reactive Oxygen Species - metabolism ; Spin Labels ; Superoxides - metabolism ; Thiobarbituric Acid Reactive Substances - metabolism ; Vasoconstrictor Agents - pharmacology ; Vasoconstrictor Agents - toxicity</subject><ispartof>Hypertension (Dallas, Tex. 1979), 2003-10, Vol.42 (4, Part 2), p.806-810</ispartof><rights>2003 American Heart Association, Inc.</rights><rights>2004 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Oct 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5760-945b0ffd59a09271d15f73cc312a382a7def5e02a3fb2c948768e64d050461583</citedby><cites>FETCH-LOGICAL-c5760-945b0ffd59a09271d15f73cc312a382a7def5e02a3fb2c948768e64d050461583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3673,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15183002$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12874096$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sedeek, Mona H</creatorcontrib><creatorcontrib>Llinas, Maria T</creatorcontrib><creatorcontrib>Drummond, Heather</creatorcontrib><creatorcontrib>Fortepiani, Lourdes</creatorcontrib><creatorcontrib>Abram, Sean R</creatorcontrib><creatorcontrib>Alexander, Barbara T</creatorcontrib><creatorcontrib>Reckelhoff, Jane F</creatorcontrib><creatorcontrib>Granger, Joey P</creatorcontrib><title>Role of Reactive Oxygen Species in Endothelin-Induced Hypertension</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>ABSTRACT—Recent reports have indicated that endothelin-induced vasoconstriction in isolated aortic vascular rings may be mediated by the production of superoxide anion. The purpose of this study was to determine the role of superoxide anion in mediating the chronic renal and hypertensive actions of endothelin. Endothelin-1 (5 pmol/kg per minute) was chronically infused into the jugular vein by use of mini-osmotic pump for 9 days in male Sprague-Dawley rats and in rats treated with the superoxide anion scavenger tempol (30 mg/kg per day). Mean arterial pressure in the endothelin-1–treated rats was 141±3 mm Hg, compared with 125±2 mm Hg in control rats. Endothelin-1 increased renal vascular resistance (15.3±2.5 versus 10±1.3 mm Hg/mL per minute) and decreased renal plasma flow (6.5±0.9 versus 8.7±0.7 mL/min) in control rats. Endothelin-1 also significantly increased TBARS in the kidney and urinary 8-isoprostaglandin F2α excretion. The increase in arterial pressure in response to endothelin-1 was completely abolished by tempol (127±4 versus 127±4 mm Hg). Tempol also markedly attenuated the renal plasma flow and renal vascular resistance response to endothelin-1. Tempol also significantly decreased the level of 8-isoprostaglandin F2α in the endothelin-1–treated rats. Tempol had no effect on arterial pressure or renal hemodynamics in control rats. These data indicate that formation of reactive oxygen species may play an important role in mediating hypertension induced by chronic elevations in endothelin.</description><subject>Animals</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cells, Cultured</subject><subject>Chronic Disease</subject><subject>Cyclic N-Oxides - pharmacology</subject><subject>Dinoprost - analogs &amp; derivatives</subject><subject>Endothelin-1 - pharmacology</subject><subject>Endothelin-1 - toxicity</subject><subject>Experimental diseases</subject><subject>F2-Isoprostanes - urine</subject><subject>Free Radical Scavengers - pharmacology</subject><subject>Hemodynamics - drug effects</subject><subject>Hypertension - chemically induced</subject><subject>Hypertension - metabolism</subject><subject>Hypertension - physiopathology</subject><subject>Kidney - metabolism</subject><subject>Kidney - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Muscle, Smooth, Vascular - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Spin Labels</subject><subject>Superoxides - metabolism</subject><subject>Thiobarbituric Acid Reactive Substances - metabolism</subject><subject>Vasoconstrictor Agents - pharmacology</subject><subject>Vasoconstrictor Agents - toxicity</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkN1q20AQRpfQkLhpXqGIQC-lzOyPVts7O6R1IJCSttBcLevVqFaqSM6u1NRv301s8NwMM5yZDw5jFwgFYomXgMXy4VsBr1VJoXlh0AheLOZHbIaKy1yqUrxjM0Ajc4P465S9j_ERAKWU-oSdIq-0BFPO2OJ-6CgbmuyenB_bv5Td_dv-pj77viHfUszaPrvu62FcU9f2-U1fT57qbLndUBipj-3Qf2DHjesine_7Gfv55frH1TK_vft6czW_zb3SJeRGqhU0Ta2MA8M11qgaLbwXyJ2ouNM1NYogDc2KeyMrXVZUyhoUyBJVJc7Yxe7vJgzPE8XRPg5T6FOk5aC4FgbKBH3eQT4MMQZq7Ca0Ty5sLYJ9tWcBbbJnD_bsmz27mKfjj_uEafVE9eF0rysBn_aAi951TXC9b-OBU1gJAJ44ueNehm6kEP900wsFuybXjeu3aMnLKucAAhMPedoIEP8BcL2GLg</recordid><startdate>200310</startdate><enddate>200310</enddate><creator>Sedeek, Mona H</creator><creator>Llinas, Maria T</creator><creator>Drummond, Heather</creator><creator>Fortepiani, Lourdes</creator><creator>Abram, Sean R</creator><creator>Alexander, Barbara T</creator><creator>Reckelhoff, Jane F</creator><creator>Granger, Joey P</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope></search><sort><creationdate>200310</creationdate><title>Role of Reactive Oxygen Species in Endothelin-Induced Hypertension</title><author>Sedeek, Mona H ; Llinas, Maria T ; Drummond, Heather ; Fortepiani, Lourdes ; Abram, Sean R ; Alexander, Barbara T ; Reckelhoff, Jane F ; Granger, Joey P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5760-945b0ffd59a09271d15f73cc312a382a7def5e02a3fb2c948768e64d050461583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cells, Cultured</topic><topic>Chronic Disease</topic><topic>Cyclic N-Oxides - pharmacology</topic><topic>Dinoprost - analogs &amp; derivatives</topic><topic>Endothelin-1 - pharmacology</topic><topic>Endothelin-1 - toxicity</topic><topic>Experimental diseases</topic><topic>F2-Isoprostanes - urine</topic><topic>Free Radical Scavengers - pharmacology</topic><topic>Hemodynamics - drug effects</topic><topic>Hypertension - chemically induced</topic><topic>Hypertension - metabolism</topic><topic>Hypertension - physiopathology</topic><topic>Kidney - metabolism</topic><topic>Kidney - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Muscle, Smooth, Vascular - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Spin Labels</topic><topic>Superoxides - metabolism</topic><topic>Thiobarbituric Acid Reactive Substances - metabolism</topic><topic>Vasoconstrictor Agents - pharmacology</topic><topic>Vasoconstrictor Agents - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sedeek, Mona H</creatorcontrib><creatorcontrib>Llinas, Maria T</creatorcontrib><creatorcontrib>Drummond, Heather</creatorcontrib><creatorcontrib>Fortepiani, Lourdes</creatorcontrib><creatorcontrib>Abram, Sean R</creatorcontrib><creatorcontrib>Alexander, Barbara T</creatorcontrib><creatorcontrib>Reckelhoff, Jane F</creatorcontrib><creatorcontrib>Granger, Joey P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sedeek, Mona H</au><au>Llinas, Maria T</au><au>Drummond, Heather</au><au>Fortepiani, Lourdes</au><au>Abram, Sean R</au><au>Alexander, Barbara T</au><au>Reckelhoff, Jane F</au><au>Granger, Joey P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Reactive Oxygen Species in Endothelin-Induced Hypertension</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2003-10</date><risdate>2003</risdate><volume>42</volume><issue>4, Part 2</issue><spage>806</spage><epage>810</epage><pages>806-810</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>ABSTRACT—Recent reports have indicated that endothelin-induced vasoconstriction in isolated aortic vascular rings may be mediated by the production of superoxide anion. The purpose of this study was to determine the role of superoxide anion in mediating the chronic renal and hypertensive actions of endothelin. Endothelin-1 (5 pmol/kg per minute) was chronically infused into the jugular vein by use of mini-osmotic pump for 9 days in male Sprague-Dawley rats and in rats treated with the superoxide anion scavenger tempol (30 mg/kg per day). Mean arterial pressure in the endothelin-1–treated rats was 141±3 mm Hg, compared with 125±2 mm Hg in control rats. Endothelin-1 increased renal vascular resistance (15.3±2.5 versus 10±1.3 mm Hg/mL per minute) and decreased renal plasma flow (6.5±0.9 versus 8.7±0.7 mL/min) in control rats. Endothelin-1 also significantly increased TBARS in the kidney and urinary 8-isoprostaglandin F2α excretion. The increase in arterial pressure in response to endothelin-1 was completely abolished by tempol (127±4 versus 127±4 mm Hg). Tempol also markedly attenuated the renal plasma flow and renal vascular resistance response to endothelin-1. Tempol also significantly decreased the level of 8-isoprostaglandin F2α in the endothelin-1–treated rats. Tempol had no effect on arterial pressure or renal hemodynamics in control rats. These data indicate that formation of reactive oxygen species may play an important role in mediating hypertension induced by chronic elevations in endothelin.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>12874096</pmid><doi>10.1161/01.HYP.0000084372.91932.BA</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0194-911X
ispartof Hypertension (Dallas, Tex. 1979), 2003-10, Vol.42 (4, Part 2), p.806-810
issn 0194-911X
1524-4563
language eng
recordid cdi_proquest_journals_205273906
source MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Ovid Autoload
subjects Animals
Arterial hypertension. Arterial hypotension
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cells, Cultured
Chronic Disease
Cyclic N-Oxides - pharmacology
Dinoprost - analogs & derivatives
Endothelin-1 - pharmacology
Endothelin-1 - toxicity
Experimental diseases
F2-Isoprostanes - urine
Free Radical Scavengers - pharmacology
Hemodynamics - drug effects
Hypertension - chemically induced
Hypertension - metabolism
Hypertension - physiopathology
Kidney - metabolism
Kidney - physiopathology
Male
Medical sciences
Muscle, Smooth, Vascular - metabolism
Rats
Rats, Sprague-Dawley
Reactive Oxygen Species - metabolism
Spin Labels
Superoxides - metabolism
Thiobarbituric Acid Reactive Substances - metabolism
Vasoconstrictor Agents - pharmacology
Vasoconstrictor Agents - toxicity
title Role of Reactive Oxygen Species in Endothelin-Induced Hypertension
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T08%3A05%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Reactive%20Oxygen%20Species%20in%20Endothelin-Induced%20Hypertension&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Sedeek,%20Mona%20H&rft.date=2003-10&rft.volume=42&rft.issue=4,%20Part%202&rft.spage=806&rft.epage=810&rft.pages=806-810&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/01.HYP.0000084372.91932.BA&rft_dat=%3Cproquest_cross%3E420432041%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=205273906&rft_id=info:pmid/12874096&rfr_iscdi=true